OLE Therapy for Bronchiectasis
OLE Therapy With BE Patients in Home Care Study
Recruiting
N/A
Interventional Study
Bronchiectasis
Pulmonary Exacerbation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 5 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 85 (estimated)
- Sponsor
- Delve Health · Other
Who this trial is looking for
This trial is looking for patients with bronchiectasis who have had breathing problems recently. Participants will use a new device called BiWaze Clear to help clear their airways over a period of six months.
Are You a Good Fit for This Trial?
You may be able to join if
- I am older than 5 years old
- I have been diagnosed with bronchiectasis
- I have had one or more breathing problems in the last 6 months
- I can do the BiWaze Clear therapy as instructed
- I am stable in my breathing at the time of screening
- I can provide signed consent
You may not be able to join if
- I have a rapidly progressing neuromuscular disease
- I need to be hospitalized in the next six months
- I had a pneumothorax in the last 6 months
- I have used OLE therapy in the last 12 months
- I am currently enrolled in a different study
- I smoke or have used tobacco in the last 30 days
- I am pregnant or breastfeeding
- I have significant medical conditions that affect my health
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study will examine how the performance of Oscillating Lung Expansion (OLE) therapy affects the respiratory health of patients with Bronchiectasis (BE).
The patient will use the BiWaze Clear system for their airway clearance therapy, instead of their previously prescribed therapy. BiWaze Clear is an FDA-cleared respiratory therapy for assisting patients in loosening and mobilizing secretions a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
To be eligible to participate in this study, an individual must meet all of the following criteria:
1. Patients aged \> 5 years old.
2. History of one or more respiratory exacerbations in the past 6 months or two or more respiratory exacerbations in the past 12 months, which req…
Contacts